DK3057979T3 - Proteiner med diagnostiske og terapeutiske anvendelser - Google Patents
Proteiner med diagnostiske og terapeutiske anvendelser Download PDFInfo
- Publication number
- DK3057979T3 DK3057979T3 DK14789350.7T DK14789350T DK3057979T3 DK 3057979 T3 DK3057979 T3 DK 3057979T3 DK 14789350 T DK14789350 T DK 14789350T DK 3057979 T3 DK3057979 T3 DK 3057979T3
- Authority
- DK
- Denmark
- Prior art keywords
- diagnostic
- proteins
- therapeutic applications
- therapeutic
- applications
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
- C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/34—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/08—Materials for coatings
- A61L29/085—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
- A61L29/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/08—Materials for coatings
- A61L31/10—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/472—Complement proteins, e.g. anaphylatoxin, C3a, C5a
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/315—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Streptococcus (G), e.g. Enterococci
- G01N2333/3156—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4716—Complement proteins, e.g. anaphylatoxin, C3a, C5a
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Vascular Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Transplantation (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Urology & Nephrology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1318170.6A GB201318170D0 (en) | 2013-10-14 | 2013-10-14 | Proteins with Diagnostic and Therapeutic Uses |
PCT/GB2014/053072 WO2015055991A1 (en) | 2013-10-14 | 2014-10-13 | Proteins with diagnostic and therapeutic uses |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3057979T3 true DK3057979T3 (da) | 2020-06-22 |
Family
ID=49680023
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK14789350.7T DK3057979T3 (da) | 2013-10-14 | 2014-10-13 | Proteiner med diagnostiske og terapeutiske anvendelser |
Country Status (11)
Country | Link |
---|---|
US (4) | US10035827B2 (da) |
EP (2) | EP3757115A1 (da) |
JP (3) | JP6691042B2 (da) |
CN (3) | CN114028538A (da) |
AU (3) | AU2014335925B2 (da) |
BR (1) | BR112016008055A2 (da) |
CA (1) | CA2925663A1 (da) |
DK (1) | DK3057979T3 (da) |
ES (1) | ES2800599T3 (da) |
GB (1) | GB201318170D0 (da) |
WO (1) | WO2015055991A1 (da) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017075189A1 (en) * | 2015-10-27 | 2017-05-04 | University Of Massachusetts | Factor h-fc immunotherapy |
WO2017114401A1 (zh) * | 2015-12-31 | 2017-07-06 | 江苏匡亚生物医药科技有限公司 | 具有补体调节活性的重组补体因子h-免疫球蛋白融合蛋白及其制备方法与应用 |
GB201800620D0 (en) | 2018-01-15 | 2018-02-28 | Univ Manchester | C3b Binding Polypeptide |
JP2022541275A (ja) * | 2019-07-17 | 2022-09-22 | ジェミニ・セラピューティクス・サブ・インコーポレイテッド | H因子増強性抗体及びその使用 |
EP4001301A1 (en) * | 2020-11-13 | 2022-05-25 | Navigo Proteins Gmbh | Binding protein for complement factor h (cfh) |
GB202102931D0 (en) | 2021-03-02 | 2021-04-14 | Invizius Ltd | Peritoneal fluid composition |
GB202202728D0 (en) | 2022-02-28 | 2022-04-13 | Invizius Ltd | Peritoneal fluid composition |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5168062A (en) | 1985-01-30 | 1992-12-01 | University Of Iowa Research Foundation | Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence |
US4980286A (en) | 1985-07-05 | 1990-12-25 | Whitehead Institute For Biomedical Research | In vivo introduction and expression of foreign genetic material in epithelial cells |
CH680045A5 (da) * | 1990-02-16 | 1992-06-15 | Om Lab Sa | |
US6592876B1 (en) * | 1993-04-20 | 2003-07-15 | Uab Research Foundation | Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products |
EP0885965A3 (en) * | 1997-06-20 | 2000-01-12 | Smithkline Beecham Corporation | Histidine kinase polypeptides |
KR20060126844A (ko) * | 1998-04-07 | 2006-12-08 | 메디뮨 인코포레이티드 | 백신용 폐렴 구균의 콜린 결합성 단백질의 유도체 |
US6858706B2 (en) * | 1998-04-07 | 2005-02-22 | St. Jude Children's Research Hospital | Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof |
EP1073450A4 (en) | 1998-04-23 | 2003-04-23 | Uab Research Foundation | PNEUMOCOCCAL SURFACE PROTEIN C (PSPC), EPITOPIC REGIONS, SELECTION OF CORRESPONDING STRES AND USES |
US20010016200A1 (en) * | 1998-04-23 | 2001-08-23 | Briles David E. | Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor |
GB9816337D0 (en) * | 1998-07-27 | 1998-09-23 | Cortecs Uk Ltd | Proteins |
PL200134B1 (pl) | 1999-05-07 | 2008-12-31 | Genentech Inc | Zastosowanie przeciwciała anty-CD20 |
CA2379327A1 (en) * | 1999-06-10 | 2000-12-21 | Uab Research Foundation | Pneumococcal surface protein combination vaccine |
WO2002008426A2 (en) * | 2000-07-20 | 2002-01-31 | Hansa Medical Ab | Fh-binding protein of streptococcus pneumoniae |
JP2004504056A (ja) * | 2000-07-20 | 2004-02-12 | ハンサ メディカル アクチボラゲット | タンパク質 |
US6957392B2 (en) * | 2002-01-16 | 2005-10-18 | Laszlo Systems, Inc. | Interface engine providing a continuous user interface |
DE10258924A1 (de) * | 2002-12-17 | 2004-07-08 | Eberhard-Karls-Universität Tübingen Universitätsklinikum | Mit die Adhäsion von biologischem Material vermittelnden Substanzen beschichtete Vorrichtung |
JP5219803B2 (ja) * | 2005-05-13 | 2013-06-26 | ノバルティス ヴァクシンズ アンド ダイアグノスティクス, インコーポレイテッド | グラム陽性菌の血清耐性因子 |
EP1843375B1 (de) * | 2006-04-05 | 2011-07-06 | ABB Technology AG | Elektromagnetischer Aktuator, insbesondere für einen Mittelspannungsschalter |
DE102010001914A1 (de) * | 2010-02-15 | 2011-08-18 | Robert Bosch GmbH, 70469 | Lenkvorrichtung für ein Kraftfahrzeug |
WO2012072769A1 (en) * | 2010-12-01 | 2012-06-07 | Novartis Ag | Pneumococcal rrgb epitopes and clade combinations |
EP2655400B1 (en) * | 2010-12-20 | 2015-09-02 | The Trustees Of The University Of Pennsylvania | Factor h binding peptides and uses thereof |
WO2012134975A1 (en) * | 2011-03-28 | 2012-10-04 | St. Jude Children's Research Hospital | Methods and compositions employing immunogenic fusion proteins |
JP6057265B2 (ja) | 2013-08-21 | 2017-01-11 | 国立大学法人大阪大学 | 標的物質とリガンドとの結合親和性を測定するための方法、ならびに該方法に使用するための試薬助剤およびキット |
-
2013
- 2013-10-14 GB GBGB1318170.6A patent/GB201318170D0/en not_active Ceased
-
2014
- 2014-10-13 EP EP20176131.9A patent/EP3757115A1/en active Pending
- 2014-10-13 CN CN202110888795.4A patent/CN114028538A/zh active Pending
- 2014-10-13 EP EP14789350.7A patent/EP3057979B1/en active Active
- 2014-10-13 CN CN202110888802.0A patent/CN114031676A/zh active Pending
- 2014-10-13 DK DK14789350.7T patent/DK3057979T3/da active
- 2014-10-13 ES ES14789350T patent/ES2800599T3/es active Active
- 2014-10-13 WO PCT/GB2014/053072 patent/WO2015055991A1/en active Application Filing
- 2014-10-13 CN CN201480056203.0A patent/CN105764918B/zh active Active
- 2014-10-13 JP JP2016522745A patent/JP6691042B2/ja active Active
- 2014-10-13 BR BR112016008055A patent/BR112016008055A2/pt not_active Application Discontinuation
- 2014-10-13 US US15/029,399 patent/US10035827B2/en active Active
- 2014-10-13 AU AU2014335925A patent/AU2014335925B2/en active Active
- 2014-10-13 CA CA2925663A patent/CA2925663A1/en active Pending
-
2018
- 2018-07-06 US US16/028,740 patent/US10774116B2/en active Active
-
2019
- 2019-03-15 AU AU2019201829A patent/AU2019201829B2/en active Active
- 2019-10-28 JP JP2019195276A patent/JP6987825B2/ja active Active
-
2020
- 2020-08-17 US US16/995,344 patent/US20210017239A1/en not_active Abandoned
- 2020-11-25 AU AU2020277188A patent/AU2020277188B2/en active Active
-
2021
- 2021-09-24 US US17/483,920 patent/US20220009974A1/en active Pending
- 2021-12-01 JP JP2021195598A patent/JP7320585B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
AU2014335925A1 (en) | 2016-04-21 |
CA2925663A1 (en) | 2015-04-23 |
EP3057979B1 (en) | 2020-05-27 |
US10035827B2 (en) | 2018-07-31 |
JP2020039342A (ja) | 2020-03-19 |
JP2022031835A (ja) | 2022-02-22 |
ES2800599T3 (es) | 2021-01-04 |
AU2014335925B2 (en) | 2019-01-03 |
US10774116B2 (en) | 2020-09-15 |
EP3057979A1 (en) | 2016-08-24 |
EP3757115A1 (en) | 2020-12-30 |
BR112016008055A2 (pt) | 2017-10-03 |
AU2020277188B2 (en) | 2022-08-25 |
CN114031676A (zh) | 2022-02-11 |
GB201318170D0 (en) | 2013-11-27 |
AU2019201829A1 (en) | 2019-04-04 |
CN105764918B (zh) | 2021-08-27 |
JP6691042B2 (ja) | 2020-04-28 |
JP2017501110A (ja) | 2017-01-12 |
WO2015055991A1 (en) | 2015-04-23 |
CN114028538A (zh) | 2022-02-11 |
JP7320585B2 (ja) | 2023-08-03 |
US20210017239A1 (en) | 2021-01-21 |
AU2019201829B2 (en) | 2020-08-27 |
CN105764918A (zh) | 2016-07-13 |
AU2020277188A1 (en) | 2020-12-24 |
US20190100563A1 (en) | 2019-04-04 |
US20220009974A1 (en) | 2022-01-13 |
US20160237125A1 (en) | 2016-08-18 |
JP6987825B2 (ja) | 2022-01-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3043784T3 (da) | Arylethere og anvendelser deraf | |
DK3283106T3 (da) | Terapeutiske antistoffer og anvendelser deraf | |
DK3027204T3 (da) | Flerdelte signaleringsproteiner og anvendelser deraf | |
DK3089994T3 (da) | Fabs-in-tandem-immunglobulin og anvendelser deraf | |
DK2970460T3 (da) | Anti-IL-33-antistoffer og anvendelser deraf | |
DK3019533T3 (da) | Dobbeltspiraliserede immunoglobulinfusionproteiner og sammensætninger deraf | |
DK3083616T3 (da) | Bicykliske heterocykliske forbindelser og disses anvendelser i terapi | |
DK2963056T3 (da) | Insulinanalog og anvendelse deraf | |
DK2968443T3 (da) | Hepcidinanaloger og anvendelser deraf | |
BR302013004536S1 (pt) | Configuração aplicada em curativo médico | |
DK2920313T3 (da) | Rekombinante adenovira og anvendelse deraf | |
DK3043763T3 (da) | Stimulerings- og behandlingsindretning | |
DK3381917T3 (da) | Imidazopyridinforbindelser og anvendelser deraf | |
BR302013004419S1 (pt) | Configuração aplicada em instrumento médico | |
BR302013004565S1 (pt) | Configuração aplicada em curativo médico | |
DK3003039T3 (da) | Methyl/fluor-pyridinyl-metoxy-substituerede pyridinon-pyridinyl-forbindelser og fluor-pyrimidinyl-metoxy-substituerede pyridinon-pyridinyl-forbindelser | |
DK2962100T3 (da) | Tuberkulosebiomarkører og anvendelser deraf | |
DK3003117T3 (da) | Videolaryngoskop og laryngoskopindføringsdel | |
DK3029038T3 (da) | Tetrazolinonforbindelse og anvendelse deraf | |
DK3077467T3 (da) | Sikkativsammensætning og anvendelse deraf | |
DK3063144T3 (da) | Antiparasitære og pesticid-isoxazolinforbindelser | |
DK3030549T3 (da) | Pyridazinonforbindelser og anvendelser deraf | |
DK3057979T3 (da) | Proteiner med diagnostiske og terapeutiske anvendelser | |
DK3020408T3 (da) | Traditionel kinesisk medicinsammensætning og fremstilling og anvendelse heraf | |
DK2805670T3 (da) | Forbedringer af og i sammenhæng med oftalmoskoper |